News
Feature Story
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
SANTA CLARA, California, March 11, 2026 — Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the […]
BIOVECTRA Starts Construction on its Charlottetown mRNA Biomanufacturing Centre
Charlottetown, P.E.I. (April 14, 2022) – BIOVECTRA broke ground today, with help from provincial and federal officials, on a cutting-edge facility that will manufacture […]
BIOVECTRA mRNA Vaccine and Bio-manufacturing Facility Announced
Charlottetown, P.E.I. (November 18, 2021) – BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of […]
BIOVECTRA HONOURED TO BE NAMED ONE OF CANADA’S TOP 100 EMPLOYERS 2022
Charlottetown, P.E.I. (November 12, 2021) – BIOVECTRA is proud to be selected as one of Canada’s Top 100 Employers for 2022 and considered amongst some […]
BIOVECTRA ANNOUNCES APPOINTMENT OF GORDON C. MCCAULEY AND STEVEN M. KLOSK TO BOARD
Charlottetown, P.E.I. (October 21, 2021) – BIOVECTRA, a leading Canadian biotech and pharmaceutical CDMO has appointed Gordon C. McCauley, President and CEO of adMare BioInnovations […]
BIOVECTRA Enhances Manufacturing Capacity and Flexibility with ABEC’s CSR® Large-Scale, Single-Use Microbial Fermentation Technology
For immediate release ABEC’s Custom Single Run (CSR) fermentation solutions offer working volumes up to 1,000 liters Bethlehem, PA, USA, and Charlottetown, CANADA, September 20, […]
PhaseBio Pharmaceuticals and BIOVECTRA Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
MALVERN, Pa. & SAN DIEGO — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company […]
